Advantech Capital is a venture capital firm that focuses on innovation-driven growth capital in China. Their investment strategy primarily targets the TMT (Technology, Media, and Telecommunications), E-services, and Healthcare sectors.
50% of their portfolio is in Biotech & Life Sciences. Their most common stage is series-b (50% of deals).
Portfolio
2
Fund Size
$560M
Top Stage
Series B
Last 12 Mo
0
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
2 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Ablaze Pharmaceuticals | Series A | $75M | Nov 2021 |
 Petuum | Series B | $93M | Oct 2017 |
Top Co-Investors
Last updated: 28 April 2026